With over 40 years of pharmaceutical research and development experience, Arcinova delivers fully integrated, CMC programmes to streamline early development and regulatory submission.

Whether you're navigating complex chemistry, rigorous timelines or seeking clarity on your formulation development strategy, our team is here to help. If you would like to learn more, fill out our short questionnaire here and we will be in touch to share how our drug development experts can help simplify the interface between drug substance and drug product—accelerating your molecule’s path from concept to clinic.

Leveraging decades of interdisciplinary expertise within a single-site team, our philosophy focuses on getting your API right the first time, identifying optimal salt forms and polymorphic landscape early, to de-risk your process and path to the clinic. Once the ideal form is identified, we seamlessly transition into formulation development for non-clinical studies, maintaining a clear line-of-sight to clinical requirements. Read this case study to see how our integrated approach helped accelerate timelines for early-phase drug development.

We understand that you may not have all the answers yet—and that’s okay. Rather than seeing this as a challenge, we view it as an opportunity to share our expertise helping you get your API right first time, and co-create a pathway that shapes the future of your drug.

Arcinova is trusted for translating drug substances from discovery through preclinical development and into clinical studies. 

At Arcinova, we believe that meaningful collaboration starts the moment we first connect. That is why we prioritise early engagement with potential clients—offering bespoke advice and tailored solutions that ensure every stage, from proposal to delivery, aligns with your specific requirements.